Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zean Zhao

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Bioorganic Chemistry|April 26, 2024
Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemiaFengxin Zheng, Suiqing Mai, Xiaolin Cen, et al.
European Journal of Medicinal Chemistry|August 24, 2022
Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agentsZean Zhao, Jin Liu, Lin Yuan, et al.
Bioorganic Chemistry|February 8, 2023
Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activityZean Zhao, Jian Luo, Hui Liao, et al.
Nature Communications|August 11, 2025
Discovery of multi-target anti-gout agents from Eurycoma longifolia Jack through phenotypic screening and structural optimizationZhijiao Zhang, Xiaoyu Shi, Ting Wu, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Bioorganic Chemistry|April 26, 2024
Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemiaFengxin Zheng, Suiqing Mai, Xiaolin Cen, et al.
European Journal of Medicinal Chemistry|August 24, 2022
Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agentsZean Zhao, Jin Liu, Lin Yuan, et al.
Bioorganic Chemistry|February 8, 2023
Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activityZean Zhao, Jian Luo, Hui Liao, et al.
Nature Communications|August 11, 2025
Discovery of multi-target anti-gout agents from Eurycoma longifolia Jack through phenotypic screening and structural optimizationZhijiao Zhang, Xiaoyu Shi, Ting Wu, et al.
Pageof 3